Background: Insulinomas are the most common neuroendocrine neoplasms of the pancreas. Diagnosis is made through patient clinical presentation with hypoglycemia symptoms and imaging, such as EUS, CT, MRI, and functional imaging. Exendin-4 PET/CT (and SPECT/CT) is a new prominent radiotracer developed to image insulinomas. The aim of the study is to evaluate whether exendin-4 imaging is a useful tool in imaging for insulinoma patients when other imaging methods do not reach them. Methods: MEDLINE research conducted on PubMed, Scopus, and Web of Science gathered a total of 501 papers. Studies that evaluated exendin-4 SPECT and PET in insulinoma patients were screened and assessed through QUADAS-2 for risk of bias and applicability concerns' assessment. Sensitivity, specificity, and accuracy were reported when available. Results: A total of 13 studies were deemed eligible for a QUADAS 2 review. Studies included ranged from 2009 to 2022. The most-used tracer was Ga-68-DOTA-exendin-4 in PET and In-111-DTPA-exendin-4 in SPECT. Exendin-4 labeled with (99)mTc was also reported. The QUADAS-2 risk of bias assessment was overall low, with some unclear reports in the reference and index domains. Only two domains were at high risk of bias because of an explicated non-blind imaging review. Applicability concerns for bias were low in all domains. Reported sensitivities ranged from 95% to 100% and specificities from 20% to 100%. Conclusions: exendin-4 imaging is a sensitive functional imaging tracer in both SPECT and PET applications, especially in suspicion of benign insulinomas located where endoscopic ultrasound cannot reach, being more sensitive than morfostructural imaging.

Role of Exendin-4 functional imaging in diagnosis of insulinoma: a systematic review / Sidrak, Marko Magdi Abdou; De Feo, Maria Silvia; Corica, Ferdinando; Gorica, Joana; Conte, Miriam; Filippi, Luca; Evangelista, Laura; De Vincentis, Giuseppe; Frantellizzi, Viviana. - In: LIFE. - ISSN 2075-1729. - 13:4(2023). [10.3390/life13040989]

Role of Exendin-4 functional imaging in diagnosis of insulinoma: a systematic review

Sidrak, Marko Magdi Abdou
Primo
;
De Feo, Maria Silvia
Secondo
;
Corica, Ferdinando;Gorica, Joana;Conte, Miriam;De Vincentis, Giuseppe
Penultimo
;
Frantellizzi, Viviana
Ultimo
2023

Abstract

Background: Insulinomas are the most common neuroendocrine neoplasms of the pancreas. Diagnosis is made through patient clinical presentation with hypoglycemia symptoms and imaging, such as EUS, CT, MRI, and functional imaging. Exendin-4 PET/CT (and SPECT/CT) is a new prominent radiotracer developed to image insulinomas. The aim of the study is to evaluate whether exendin-4 imaging is a useful tool in imaging for insulinoma patients when other imaging methods do not reach them. Methods: MEDLINE research conducted on PubMed, Scopus, and Web of Science gathered a total of 501 papers. Studies that evaluated exendin-4 SPECT and PET in insulinoma patients were screened and assessed through QUADAS-2 for risk of bias and applicability concerns' assessment. Sensitivity, specificity, and accuracy were reported when available. Results: A total of 13 studies were deemed eligible for a QUADAS 2 review. Studies included ranged from 2009 to 2022. The most-used tracer was Ga-68-DOTA-exendin-4 in PET and In-111-DTPA-exendin-4 in SPECT. Exendin-4 labeled with (99)mTc was also reported. The QUADAS-2 risk of bias assessment was overall low, with some unclear reports in the reference and index domains. Only two domains were at high risk of bias because of an explicated non-blind imaging review. Applicability concerns for bias were low in all domains. Reported sensitivities ranged from 95% to 100% and specificities from 20% to 100%. Conclusions: exendin-4 imaging is a sensitive functional imaging tracer in both SPECT and PET applications, especially in suspicion of benign insulinomas located where endoscopic ultrasound cannot reach, being more sensitive than morfostructural imaging.
2023
PET; SPECT; exendin-4; insulinoma
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Role of Exendin-4 functional imaging in diagnosis of insulinoma: a systematic review / Sidrak, Marko Magdi Abdou; De Feo, Maria Silvia; Corica, Ferdinando; Gorica, Joana; Conte, Miriam; Filippi, Luca; Evangelista, Laura; De Vincentis, Giuseppe; Frantellizzi, Viviana. - In: LIFE. - ISSN 2075-1729. - 13:4(2023). [10.3390/life13040989]
File allegati a questo prodotto
File Dimensione Formato  
Sidrak_Role of Exendin-4_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.6 MB
Formato Adobe PDF
1.6 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1679962
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 4
social impact